An international team of researchers based in Peru has developed a cheaper, faster and more accurate method of diagnosing TB and its multi-drug resistant strains. It is hoped that the work, funded by the Wellcome Trust, could ensure that people with TB and drug-resistant forms of the disease are identified and treated appropriately earlier than is currently the case, reducing both the severity of their disease and their chances of infection others.